Fig. 2. A STING-activating minimalist nanovaccine (STAMINA) inhibits tumor growth and survival in tumor-bearing mice.

a Schematic of STAMINA to boost tumor-specific T cell immunity. In the HPV tumor model, tumor growth inhibition (b) and survival data (c) in C57BL/6 mice showed strong antitumor immunity after tumor inoculation with TC-1 tumor cells. Reprinted with permission from ref. [3] (Copyright 2017, with permission from Elsevier).